Results 21 to 30 of about 266,598 (267)

Late Onset Dipeptidyl Peptidase -4 Inhibitor Associated Seronegative Rheumatoid Arthritis

open access: yesJournal of Nepal Health Research Council, 2021
Drug-induced arthritis is not an uncommon scenario. DPP-4 inhibitors could potentially cause adverse-events mediated by cytokine-induced inflammation leading to arthritis. The activity of the DPP-4 enzyme could be inversely related to the development of
Binit Vaidya   +3 more
doaj   +1 more source

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

open access: yesRMD Open, 2023
Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels changed over 2 years and whether they predicted gout ...
Tore K Kvien   +5 more
doaj   +1 more source

Photosensitivity in Rheumatic Diseases [PDF]

open access: yesJournal of Investigative Dermatology Symposium Proceedings, 2004
There have been a number of recent advances in the genetic understanding of photosensitive rheumatic diseases, especially subacute cutaneous lupus erythematosus and dermatomyositis. These advances support the concept that increased numbers of ultraviolet light-induced apoptotic cells in skin lead to a supra-threshold concentration of antigenic peptides.
Werth, Victoria P.   +2 more
openaire   +2 more sources

Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis

open access: yesJournal of Ayurveda and Integrative Medicine, 2018
Background: Data on long term use of Ayurvedic drugs is sparse. They may prove useful if combined with modern medicine in certain clinical situations (integrative medicine).
Arvind Chopra   +4 more
doaj   +1 more source

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

open access: yesBMC Health Services Research, 2023
Background Remote care has the potential of improving access to timely care for people with inflammatory joint diseases (IJD), but there is limited knowledge on how this approach is regarded by healthcare professionals (HCP).
Emil Eirik Kvernberg Thomassen   +4 more
doaj   +1 more source

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis

open access: yesArthritis Research & Therapy, 2019
Background Structural variations such as copy number variations (CNVs) have a functional impact on various human traits. This study profiled genome-wide CNVs in Korean patients with rheumatoid arthritis (RA) to investigate the efficacy of treatment with ...
Ki-Nam Gu   +19 more
doaj   +1 more source

The adolescent with rheumatic disease [PDF]

open access: yesArchives of Disease in Childhood, 1997
Adolescence is a period of emotional and physical upheaval and a time when personal identity, need for independence, and peer relationships all evolve. This transition from dependence to independence can be a difficult process for healthy teenagers. Those with chronic illness and disability have additional concerns, rendering them especially vulnerable
R, Sathananthan, J, David
openaire   +2 more sources

Vitamin E and Autoimmune Diseases: A Narrative Review [PDF]

open access: yesReviews in Clinical Medicine, 2018
Autoimmune diseases are characterized by the attack of the immune system to normal tissues. Patients with autoimmune diseases usually have the deficiency of dietary factors  that may be related to the etiology of these conditions.
Zahra Rezaieyazdi   +3 more
doaj   +1 more source

Cardiovascular disease in rheumatic diseases

open access: yesTerapevticheskii arkhiv, 2016
The representatives of immunoinflammatory diseases are rheumatic ones, such as primarily rheumatoid arthritis, juvenile idiopathic arthritis, spondyloarthritis, psoriatic arthritis, systemic lupus erythematosus, and other systemic connective diseases, which are characterized by a high risk for untimely death.
E L Nasonov, T V Popkova, D S Novikova
openaire   +3 more sources

Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients

open access: yesEuropean Pharmaceutical Journal, 2023
Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women.
Salari M.   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy